Substance / Medication

Aurothioglucose

Overview

Active Ingredient
aurothioglucose
RxNorm CUI
4980

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

3 trials linked to this intervention

3
Total Trials
1
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Oral Manifestations in Paraneoplastic Syndromes: A Systematic Review and Meta-Analysis.
Messina Sabrina, De Falco Domenico, Petruzzi Massimo · Oral Dis · 2025
PMID: 39415566Meta-Analysis
Oral pemphigus vulgaris diagnostic characteristics and treatment: a systematic review.
Filho Solimar Ribeiro Carlete, da Silva Luana Amorim Morais, Maia Caio Rodrigues et al. · Med Mol Morphol · 2025
PMID: 39680142Meta-Analysis
Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review.
de Carvalho Jozélio Freire, Skare Thelma Laroca · Adv Rheumatol · 2025
PMID: 40134027Meta-Analysis
MicroRNAs in patients with pemphigus: A systematic review.
Razavi Zahra, Esmaeili Nafiseh, Katebian Saba et al. · Int Immunopharmacol · 2025
PMID: 40184809Meta-Analysis
Pregnancy in pemphigus vulgaris: A systematic review.
Lan Yining, Zhang Hanlin, Jin Hongzhong · Am J Reprod Immunol · 2024
PMID: 38282607Meta-Analysis
Pemphigus vulgaris and mucous membrane pemphigoid: A systematic review of clinical manifestations, diagnosis, and treatment.
Morais Hannah Gil de Farias, Costa Carla Samily de Oliveira, Medeiros Maurília Raquel de Souto et al. · J Stomatol Oral Maxillofac Surg · 2024
PMID: 38960026Meta-Analysis
Oral biopsy in mucous membrane pemphigoid and pemphigus vulgaris with gingival expression: the optimal site. A systematic review and meta-analysis.
Dridi Sophie-Myriam, Lutz Claire Manon, Gaultier Frédérick et al. · BMC Oral Health · 2024
PMID: 39285275Meta-AnalysisFull text (PMC)
Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate.
van Roon Eric N, van de Laar Mart A F J, Janssen Matthijs et al. · J Rheumatol · 2005
PMID: 15940762Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Aurothioglucose (substance)
SNOMED CT
21880003
UMLS CUI
C0018033
RxNorm CUI
4980

Clinical Data

This intervention maps to 9 entities in the Ltrl knowledge graph.

4
Conditions
2
Biomarkers
1
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.